These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7516295)

  • 1. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study.
    Bergh C; Hillensjö T; Wikland M; Nilsson L; Borg G; Hamberger L
    Fertil Steril; 1994 Jul; 62(1):113-20. PubMed ID: 7516295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization.
    Bergh C; Carlström K; Selleskog U; Hillensjö T
    Eur J Endocrinol; 1996 Feb; 134(2):190-6. PubMed ID: 8630518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology.
    Suikkari A; MacLachlan V; Koistinen R; Seppälä M; Healy D
    Fertil Steril; 1996 Apr; 65(4):800-5. PubMed ID: 8654642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3).
    Huang ZH; Baxter RC; Hughes SM; Matson PL; Lieberman BA; Morris ID
    Hum Reprod; 1993 Jun; 8(6):850-7. PubMed ID: 7688379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
    Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
    Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial.
    Owen EJ; Shoham Z; Mason BA; Ostergaard H; Jacobs HS
    Fertil Steril; 1991 Dec; 56(6):1104-10. PubMed ID: 1743329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study.
    Rabinovici J; Cataldo NA; Dandekar P; Rosenthal SM; Gargosky SE; Gesundheit N; Martin MC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1171-6. PubMed ID: 9100591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
    Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
    Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.
    Tapanainen J; Martikainen H; Voutilainen R; Orava M; Ruokonen A; Rönnberg L
    Fertil Steril; 1992 Oct; 58(4):726-32. PubMed ID: 1426317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
    Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
    Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1, insulin-like growth factors, and insulin-like growth factor binding proteins in ovarian follicular fluid are differentially regulated by the type of ovarian hyperstimulation used for in vitro fertilization.
    Fried G; Wramsby H; Tally M
    Fertil Steril; 1998 Jul; 70(1):129-34. PubMed ID: 9660434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular fluid levels of insulin-like growth factor I, insulin-like growth factor binding protein I, and ovarian steroids collected during ovum pick-up.
    Chang SY; Hsieh KC; Wang HS; Soong YK
    Fertil Steril; 1994 Dec; 62(6):1162-7. PubMed ID: 7525360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and follicular fluid insulin like growth factors I and II during growth hormone co-treatment for in-vitro fertilization and embryo transfer.
    Owen EJ; Torresani T; West C; Mason BA; Jacobs HS
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):327-34. PubMed ID: 1752060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
    Choi YS; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-3 in the follicular fluid of women undergoing ovarian hyperstimulation with different gonadotropin preparations.
    Nardo LG; Bellanca SA; Burrello N; Longo G; D'Agata R; Nardo F; Calogero AE
    Gynecol Endocrinol; 2001 Dec; 15(6):413-20. PubMed ID: 11826764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
    Dorn C; Reinsberg J; Kupka M; van der Ven H; Schild RL
    Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Hormone Supplementation in the Luteal Phase Before Microdose GnRH Agonist Flare Protocol for In Vitro Fertilization.
    Dunne C; Seethram K; Roberts J
    J Obstet Gynaecol Can; 2015 Sep; 37(9):810-815. PubMed ID: 26605451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.